Publication:
Sunitinib in patients with metastatic non-clear renal cell carcinoma: A multicentric retpospective Turkish Oncology Group (TOG) trial.

Simple item page
dc.contributor.authorsYildiz, Ibrahim; Ekenel, Meltem; Altman, Tuley; Kocar, Muharrem; Uysal, Mukremin; Kanitez, Metin; Bayoglu, Vedat; Varol, Umut; Tural, Deniz; Avcl, Nilufer; Kaplan, Muhammet All; Surmeli, Zeki; Dede, Isa; Ulas, Arife; Yazici, Ozan; Basaran, Mert
dc.date.accessioned2022-03-12T16:14:57Z
dc.date.accessioned2026-01-11T17:39:23Z
dc.date.available2022-03-12T16:14:57Z
dc.date.issued2014
dc.identifier.doi10.1200/jco.2014.32.15_suppl.e15602
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/225514
dc.identifier.wosWOS:000358613200740
dc.language.isoeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleSunitinib in patients with metastatic non-clear renal cell carcinoma: A multicentric retpospective Turkish Oncology Group (TOG) trial.
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.issue15
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume32

Files

Collections

Araştırma Çıktıları